| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-10 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.23 | 7e-08 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-08 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.36 | 5e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.18 | 2e-05 |